Gonadorelin Acetate and TRT - Gonadorelin vs HCG TRT - Is there a HCG Ban?
A six-minute exchange on whether hCG was banned and why one speaker sees gonadorelin as a poor replacement for hCG in men on testosterone therapy.
With Unnamed main speaker (TRT and Hormone Optimization channel), Unnamed second speaker
Key moments
Tap a moment to play the video from there.
- 0:00The viewer questionA viewer asks why hCG is considered better than gonadorelin, since their clinic switched them. The speakers say they will answer in two parts.
- 0:33Reclassified, not bannedThe main speaker says the FDA did not ban hCG. He says it was reclassified from a peptide to a biologic.
- 1:03Why pharmacies need a licenseHe says compounding a biologic requires a biologic license, special equipment and sterility testing. He bases this on talks with a few pharmacy owners.
- 1:34His view of the motiveHe argues the change was meant to protect sales of the brand-name product, which he says costs about three times as much.
- 2:04hCG is still obtainableHe says licensed pharmacies still make hCG and that clinics without such an account tell patients it is unavailable. His own clinics deliver it daily.
- 2:35The hypothalamus to testicles chainHe explains the hypothalamus, pituitary and testicles, and how GnRH leads to luteinizing hormone and then to testosterone production.
- 3:05hCG versus gonadorelin mechanismHe says hCG mimics luteinizing hormone and acts on the testicles. Gonadorelin mimics GnRH and acts on the pituitary.
- 3:36Secondary and primary hypogonadismHe argues that men with secondary hypogonadism gain less from gonadorelin because the pituitary is the failing step. He says men with primary hypogonadism would gain from neither drug.
- 4:37Second speaker adds a caveatThe second speaker agrees. He says overwhelming a weak pathway might give a small push, and men with normal function might benefit.
What the video says
This short video opens with a viewer question: why is hCG considered better than gonadorelin, and what should men do when their clinics have switched them to gonadorelin? The main speaker splits it into two parts, hCG availability and the difference between the two drugs. The video is a conversation between two people. Neither is introduced by name or credential in the captions.
On availability, the main speaker says hCG was not banned by the FDA. He says it was reclassified from a peptide to a biologic, so a compounding pharmacy now needs a biologic license, specific equipment and sterility testing to make it. He describes this as a push to sell the brand-name product, which he says costs about three times as much, and calls it a way to sort of ban hCG without banning it. He says pharmacies with the right license still make it and that his clinics deliver it daily. These are his claims, drawn partly from conversations with pharmacy owners, and the video offers no regulatory documents.
On the medical difference, he walks through the chain of command from the hypothalamus to the pituitary to the testicles. He describes hCG as a mimic of luteinizing hormone that acts directly on the testicles, and gonadorelin as a mimic of GnRH that acts a step earlier, on the pituitary. He says he has not used gonadorelin with patients and is speaking from his research.
His central argument is that in secondary hypogonadism the pituitary is already failing to release enough luteinizing hormone, so gonadorelin asks it to do a job it cannot do well. He says men with primary hypogonadism would benefit from neither drug, because the testicles themselves have failed. He allows that gonadorelin may be better than nothing but does not see it as a replacement for hCG. The second speaker agrees. He adds that overwhelming a weak pathway might give a small push, and that men with normal function who are simply taking testosterone might see some benefit.
On each compound
Gonadorelin2:04
The main speaker describes gonadorelin as a GnRH analog that signals the pituitary to release luteinizing hormone. He says he knows it from research rather than patient use. He argues it is not a replacement for hCG, especially in secondary hypogonadism, and the second speaker agrees.
See how your DNA reads Gonadorelin“it was not banned by the fda it was reclassified”
What this video doesn’t settle
- The reclassification and the claimed motive behind it come from the speaker's own account and conversations with pharmacy owners, with no regulatory source shown.
- The main speaker says he has not used gonadorelin with patients, so his comparison rests on mechanism and research he does not cite.
- No clinical data, outcomes or dosing for either drug are presented.
Questions this video answers
Was hCG banned by the FDA?
According to the main speaker, no. He says it was reclassified from a peptide to a biologic, which changed the license compounding pharmacies need. He says licensed pharmacies still supply it.
Why do some clinics say hCG is unavailable?
The main speaker says a clinic without an account at a pharmacy holding a biologic license may tell patients hCG is unavailable. He says it can still be obtained through the right channels.
How does gonadorelin differ from hCG?
The main speaker says gonadorelin mimics GnRH and acts on the pituitary to release luteinizing hormone. He says hCG mimics luteinizing hormone and acts directly on the testicles.
Does gonadorelin work for secondary hypogonadism according to this video?
The main speaker says it would not help in the same way as hCG. His reasoning is that the pituitary is already failing to release enough luteinizing hormone. The second speaker agrees, while allowing that a small extra push is possible.
Who might still benefit from gonadorelin according to the speakers?
The second speaker suggests men with normal function who are just taking testosterone might get some benefit. The main speaker says it may be better than nothing but is not a replacement for hCG.
Video by TRT and Hormone Optimization on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
